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Comparison of Post-Treatment Plasma EBV DNA with Nasopharyngeal Biopsy in Patients 
after Radical (Chemo) Radiation Therapy for Non-metastatic Nasopharyngeal Cancer  
V.H. Lee, D.L.W. Kwong, K.O. Lam, H.C.K. Sze, P.P.Y. Ho, W.W.L. Chan, D.K.C. Leung, L.S. 
Wong, T.W. Leung 
PURPOSE/OBJECTIVE(S): Random nasopharyngeal biopsy after completion of intensity-
modulated radiation therapy (IMRT) for non-metastatic nasopharyngeal cancer (NPC) is routinely 
practiced in Hong Kong to confirm local remission. Plasma EBV DNA is proven an accurate 
marker for NPC. We carried out a prospective study comparing the correlation between post-
IMRT nasopharyngeal biopsy and EBV DNA, to investigate if EBV DNA can substitute biopsy 
to confirm local remission. 
MATERIALS/METHODS: Patients with non-metastatic NPC treated with definitive (chemo) 
IMRT diagnosed between January 2011 and March 2013 were recruited. After baseline workup 
including plasma EBV DNA, they received radical concurrent chemoradiation with 3 cycles of 
cisplatin 100 mg/m
2
 and IMRT 70 Gy in 35 fractions over 7 weeks to primary tumor and positive 
neck nodes and 66 Gy in 35 fractions over 7 weeks to high-risk nodal regions, followed by 3 
more cycles of adjuvant chemotherapy with cisplatin 100 mg/m
2
 Day 1 and 5-FU 1000 mg/m
2
 
Day 1-4 every 4 weeks. Eight weeks after IMRT, they had random 6-site nasopharyngeal biopsies 
regardless of endoscopic appearance together with paired plasma EBV DNA. Repeated biopsies 
were performed at 10 and 12 weeks after IMRT if residual tumor was noted in previous biopsy. 
Local remission was defined as no residual tumor 12 weeks or earlier after completion of IMRT 
while local persistence as residual tumor at 12 weeks after IMRT and salvage therapy was given. 
The percentage of EBV DNA 0 copies/ml or < 100 copies/ml in those who had local remission 
was compared with those who had persistence. Receiver operating characteristic (ROC) curve 
was examined to evaluate the performance of EBV DNA. 
RESULTS: All 214 patients completed treatment without interruption of IMRT, after a median 
follow-up of 2.2 years. Of these, 193 (90.2%) patients who had both biopsies and EBV DNA 
done were evaluated. One hundred seventy-two (89.1%), 175 (90.7%), and 176 (91.2%) patients 
achieved local remission at 8 weeks, 10 weeks, and 12 weeks, respectively. Local persistence was 
noted in 17 (8.8%) patients. One hundred seventy-one (88.6%) and 181 (93.8%) patients had their 
EBV 0 copies/ml and less than 100 copies/ml at 8 weeks. Local persistence was detected in 5.3% 
in those whose EBV DNA 0 copies/ml, not different from those whose EBV DNA > 0 copies/ml 
(9.1%, p = 0.466). This was also not different if EBV DNA was dichotomized to < 100 copies/ml 
(6.1%) vs. ≥ 100 copies/ml (0%, p = 0.379). Area of ROC curve was 0.536 (95% CI = 0.353-
0.719) and 0.467 (95% CI = 0.301-0.633) when EBV DNA 0 copies/ml and 100 copies/ml were 
chosen as cut-off, respectively. Only 1 patient (0.5%) who had local remission developed local 
relapse till the date of last follow-up. 
CONCLUSIONS: Plasma EBV DNA could not differentiate between those who had local 
remission and local persistence. Nasopharyngeal biopsy was still required after completion of 
IMRT to rule out local persistence which prompted early salvage treatment. 
